Director dealings: Reneuron CFO makes share purchase

24th Jan 2023 14:44

(Sharecast News) - Reneuron revealed on Tuesday that chief financial officer John Hawkins had acquired 100,000 ordinary shares in the AIM-listed stem cell technologies group.

Hawkins, who joined Reneuron in October 2014, purchased the shares at an average price of 9.88p each, for a total value of £9,878.

Back in December, Reneuron reported first-half revenues of £440,000, up from £60,000 a year earlier, related to income from partner-funded development activities and royalty income. The company's loss for the period totalled £3.2m, narrowing from £5.2m, driven by lower costs, increased revenue, and foreign exchange gains.

As of 1610 GMT, Reneuron shares were up 5.75% at 10.42p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Europa Metals Ltd Npv (di) (EUZ)

Director name: Campion ,Myles Stuart

Amount purchased: 1,090,859 @ 3.35p

Value: £36,543.78

Reneuron Group (RENE)

Director name: Hawkins,John

Amount purchased: 100,000 @ 9.88p

Value: £9,878.00

Europa Metals Ltd Npv (di) (EUZ)

Director name: Kirby,Evan

Amount purchased: 155,129 @ 3.44p

Value: £5,336.44

Murray International Trust (MYI)

Director name: Hardie,David

Amount purchased: 1 @ 1,304.64p

Value: £13.05

Top Director Sells